Ignite Creation Date:
2024-05-05 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000446
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
Sponsor:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Organization:
National Institute on Alcohol Abuse and Alcoholism NIAAA
Study Overview
Official Title:
Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism
Status:
COMPLETED
Status Verified Date:
2004-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate the use of sertraline Zoloft to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders This will be a 12-week placebo-controlled double-blind outpatient trial
All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline Comprehensive evaluation will be done at study entry treatment termination and 6 9 and 12 months after study entry
All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline Comprehensive evaluation will be done at study entry treatment termination and 6 9 and 12 months after study entry
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: